Health Sciences Trust (JAFMX) is an MF managed by John Hancock. Its largest position is ELI LILLY & Co (LLY), representing 10.20% of fund assets.
Health Sciences Trust Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- JAFMX
- Type:
- MF
- Manager:
- John Hancock
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 29, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
10.20% | $23,185,562.16 | 25,208 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
4.12% | $9,364,629.56 | 19,052 |
|
-
INTUITIVE SURGICAL INC
|
3.71% | $8,424,592.25 | 18,275 |
|
-
STRYKER CORP
|
3.52% | $7,999,523.55 | 24,345 |
|
-
Merck & Co., Inc.
|
3.48% | $7,901,609.52 | 65,688 |
|
-
ASTRAZENECA PLC
|
3.22% | $7,322,581.38 | 37,129 |
|
-
UNITEDHEALTH GROUP INC
|
3.13% | $7,118,952.31 | 26,309 |
|
-
ARGENX SE
|
2.99% | $6,801,548.50 | 9,314 |
|
-
AbbVie Inc.
|
2.88% | $6,551,886.25 | 30,125 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
2.69% | $6,107,719.20 | 7,905 |
|
-
GILEAD SCIENCES, INC.
|
2.64% | $6,006,847.00 | 43,100 |
|
-
JOHNSON & JOHNSON
|
2.47% | $5,615,275.68 | 22,972 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
2.46% | $5,594,253.12 | 12,528 |
|
-
DANAHER CORP /DE/
|
2.08% | $4,733,174.40 | 24,964 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
1.68% | $3,818,570.67 | 11,541 |
|
-
Ascendis Pharma A/S
|
1.45% | $3,300,573.90 | 14,430 |
|
-
UNITED THERAPEUTICS Corp
|
1.43% | $3,256,053.18 | 5,491 |
|
-
Revolution Medicines, Inc.
|
1.39% | $3,158,096.50 | 32,474 |
|
-
BeOne Medicines Ltd.
|
1.23% | $2,795,033.77 | 124,598 |
|
-
Protagonist Therapeutics, Inc
|
1.17% | $2,652,391.00 | 25,165 |
|
-
Roivant Sciences Ltd.
|
1.16% | $2,639,366.80 | 95,284 |
|
-
INSMED Inc
|
1.11% | $2,515,264.64 | 15,382 |
|
-
Summit Therapeutics Inc.
|
1.09% | $2,487,115.92 | 131,177 |
|
-
Natera, Inc.
|
1.06% | $2,411,279.43 | 12,057 |
|
-
TENET HEALTHCARE CORP
|
1.03% | $2,347,929.82 | 12,442 |
|
-
AMGEN INC
|
1.03% | $2,335,228.45 | 6,637 |
|
-
BrightSpring Health Services, Inc.
|
1.01% | $2,300,940.00 | 54,000 |
|
-
BOSTON SCIENTIFIC CORP
|
0.95% | $2,151,885.75 | 34,293 |
|
-
HCA Healthcare, Inc.
|
0.92% | $2,099,292.64 | 4,436 |
|
-
Guardant Health, Inc.
|
0.92% | $2,097,999.81 | 22,713 |
|
-
CVS HEALTH Corp
|
0.90% | $2,040,406.20 | 28,410 |
|
-
Kymera Therapeutics, Inc.
|
0.81% | $1,839,792.81 | 22,089 |
|
-
Cigna Group
|
0.78% | $1,779,222.50 | 6,670 |
|
-
CG Oncology, Inc.
|
0.72% | $1,628,110.08 | 24,056 |
|
-
CARDINAL HEALTH INC
|
0.71% | $1,616,944.12 | 7,652 |
|
-
Elevance Health, Inc.
|
0.68% | $1,549,233.00 | 5,292 |
|
-
Krystal Biotech, Inc.
|
0.68% | $1,535,454.08 | 5,944 |
|
-
Scholar Rock Holding Corp
|
0.65% | $1,469,982.32 | 29,902 |
|
-
BridgeBio Pharma, Inc.
|
0.64% | $1,450,372.06 | 19,531 |
|
-
IONIS PHARMACEUTICALS INC
|
0.64% | $1,445,407.41 | 19,249 |
|
-
CHUGAI PHARMACEUTICAL CO LTD.
|
0.61% | $1,378,710.87 | 25,000 |
|
-
Praxis Precision Medicines, Inc.
|
0.61% | $1,376,073.49 | 4,271 |
|
-
Structure Therapeutics Inc.
|
0.60% | $1,361,216.20 | 28,241 |
|
-
Celcuity Inc.
|
0.59% | $1,349,020.66 | 11,819 |
|
-
Royalty Pharma plc
|
0.58% | $1,326,802.23 | 27,659 |
|
-
CENTESSA PHARMACEUTICALS PLC
|
0.55% | $1,249,472.04 | 31,457 |
|
-
Cencora, Inc.
|
0.54% | $1,236,140.90 | 3,935 |
|
-
Vera Therapeutics, Inc.
|
0.48% | $1,101,416.94 | 27,378 |
|
-
NUVALENT INC-A
|
0.46% | $1,045,809.60 | 10,208 |
|
-
APOGEE THERAPEUTICS INC
|
0.46% | $1,035,880.19 | 12,307 |
Advertisement (320x50)